Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. uniQure N.V.

    World Rank (Aug-2026)
    4,693
    Market Cap (Aug-2026)
    3.373 Billion USD
    World Rank (Jan-05-2024)
    15,314
    Market Cap (Jan-05-2024)
    0.324 Billion USD
    World Rank (Jul-30-2023)
    13,144
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    7,966
    Market Cap (Dec-25-2022)
    1.090 Billion USD
    World Rank (Jan-07-2022)
    9,983
    Market Cap (Jan-07-2022)
    0.90 Billion USD
    Annual Revenue in USD
    524 Million USD
    Annual Net Income in USD
    329 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in Amsterdam, Netherlands.
  2. AbCellera Biologics Inc.

    World Rank (Aug-2026)
    4,707
    Market Cap (Aug-2026)
    3.353 Billion USD
    World Rank (Jan-05-2024)
    6,216
    Market Cap (Jan-05-2024)
    1.724 Billion USD
    World Rank (Jul-30-2023)
    5,362
    Market Cap (Jul-30-2023)
    2.220 Billion USD
    World Rank (Dec-25-2022)
    4,125
    Market Cap (Dec-25-2022)
    2.955 Billion USD
    World Rank (Jan-07-2022)
    4,491
    Market Cap (Jan-07-2022)
    3.33 Billion USD
    Annual Revenue in USD
    288 Million USD
    Annual Net Income in USD
    118 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ABCELLERA BIOLOGICS INC. is Biotechnology sector company with headquarters is in Vancouver, Canada.
  3. Arcutis Biotherapeutics Inc.

    World Rank (Aug-2026)
    4,757
    Market Cap (Aug-2026)
    3.292 Billion USD
    World Rank (Jan-05-2024)
    14,287
    Market Cap (Jan-05-2024)
    0.381 Billion USD
    World Rank (Jul-30-2023)
    10,942
    Market Cap (Jul-30-2023)
    0.667 Billion USD
    World Rank (Dec-25-2022)
    9,104
    Market Cap (Dec-25-2022)
    0.871 Billion USD
    World Rank (Jan-07-2022)
    9,768
    Market Cap (Jan-07-2022)
    0.94 Billion USD
    Annual Revenue in USD
    372 Million USD
    Annual Operating Income in USD
    -12 Million USD
    Annual Net Income in USD
    -16 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Arcutis Biotherapeutics is a Pioneering Medical Dermatology company dedicated to revolutionizing the treatment of serious skin diseases. It is focused on filling the innovation gap in medical dermatology drug development by applying deep clinical, product development and commercial expertise in dermatology to develop best in class therapies against biologically validated targets. It is having  29 employees as on 2019. The headquarters is in USA.
  4. NewAmsterdam Pharma Company N.V.

    World Rank (Aug-2026)
    4,823
    Market Cap (Aug-2026)
    3.225 Billion USD
    World Rank (Jan-05-2024)
    8,641
    Market Cap (Jan-05-2024)
    0.989 Billion USD
    World Rank (Jul-30-2023)
    8,861
    Market Cap (Jul-30-2023)
    0.973 Billion USD
    World Rank (Dec-25-2022)
    8,503
    Market Cap (Dec-25-2022)
    0.973 Billion USD
    Headquarters Country
  5. Disc Medicine Inc.

    World Rank (Aug-2026)
    5,015
    Market Cap (Aug-2026)
    3.027 Billion USD
    World Rank (Jan-05-2024)
    6,852
    Market Cap (Jan-05-2024)
    1.472 Billion USD
    World Rank (Jul-30-2023)
    8,317
    Market Cap (Jul-30-2023)
    1.089 Billion USD
    Annual Operating Income in USD
    -236 Million USD
    Annual Net Income in USD
    -212 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  6. Zai Lab

    World Rank (Aug-2026)
    5,125
    Market Cap (Aug-2026)
    2.908 Billion USD
    World Rank (Jan-05-2024)
    4,807
    Market Cap (Jan-05-2024)
    2.622 Billion USD
    World Rank (Jul-30-2023)
    4,184
    Market Cap (Jul-30-2023)
    3.176 Billion USD
    World Rank (Dec-25-2022)
    4,923
    Market Cap (Dec-25-2022)
    2.320 Billion USD
    World Rank (Jan-07-2022)
    3,121
    Market Cap (Jan-07-2022)
    5.31 Billion USD
    Annual Revenue in USD
    144 Million USD
    Annual Net Income in USD
    -704 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Zai Lab is an Innovative and Research Based Commercial Stage Biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. It is having 900 employees as on 2020. The headquarters is in China.

  7. Nurix Therapeutics Inc.

    World Rank (Aug-2026)
    5,235
    Market Cap (Aug-2026)
    2.807 Billion USD
    World Rank (Jan-05-2024)
    12,883
    Market Cap (Jan-05-2024)
    0.478 Billion USD
    World Rank (Jul-30-2023)
    13,148
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    12,559
    Market Cap (Dec-25-2022)
    0.489 Billion USD
    World Rank (Jan-07-2022)
    8,355
    Market Cap (Jan-07-2022)
    1.23 Billion USD
    Annual Revenue in USD
    84 Million USD
    Annual Operating Income in USD
    -286 Million USD
    Annual Net Income in USD
    -264 Million USD
    Annual Results for Period Ending
    For year ending November-2025
    Headquarters Country
    Company Profile
    Nurix Therapeutics is a  Biopharmaceutical company discovers drugs that harness the bodies natural process to control protein levels and drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells as a unique therapeutic approach to treat a broad range of diseases. The company annual revenue is 17.8 million USD and 103 employees as on 2019. The headquarters is in USA.
  8. Supernus Pharmaceuticals

    World Rank (Aug-2026)
    5,237
    Market Cap (Aug-2026)
    2.806 Billion USD
    World Rank (Jan-05-2024)
    6,703
    Market Cap (Jan-05-2024)
    1.522 Billion USD
    World Rank (Jul-30-2023)
    6,453
    Market Cap (Jul-30-2023)
    1.657 Billion USD
    World Rank (Dec-25-2022)
    5,403
    Market Cap (Dec-25-2022)
    2.026 Billion USD
    World Rank (Jan-07-2022)
    7,241
    Market Cap (Jan-07-2022)
    1.58 Billion USD
    Annual Revenue in USD
    719 Million USD
    Annual Operating Income in USD
    -62 Million USD
    Annual Net Income in USD
    -39 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Supernus Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases. The company annual revenue is 392.8 million USD and 464 employees as on 2019. The headquarters is in USA.
  9. ATAI Life Sciences N.V.

    World Rank (Aug-2026)
    5,361
    Market Cap (Aug-2026)
    2.692 Billion USD
    World Rank (Jan-05-2024)
    16,036
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    15,102
    Market Cap (Jul-30-2023)
    0.342 Billion USD
    World Rank (Dec-25-2022)
    13,197
    Market Cap (Dec-25-2022)
    0.443 Billion USD
    World Rank (Jan-07-2022)
    9,233
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Headquarters Country
    Company Profile
    Atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Headquarters is in Germany.
  10. Trevi Therapeutics

    World Rank (Aug-2026)
    5,440
    Market Cap (Aug-2026)
    2.630 Billion USD
    World Rank (Jan-05-2024)
    22,095
    Market Cap (Jan-05-2024)
    0.088 Billion USD
    World Rank (Jul-30-2023)
    20,000
    Market Cap (Jul-30-2023)
    0.138 Billion USD
    World Rank (Dec-25-2022)
    21,267
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    21,111
    Annual Operating Income in USD
    -49 Million USD
    Annual Net Income in USD
    -43 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Trevi Therapeutics is a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvio™ to treat serious chronic cough conditions by targeting the central and peripheral nervous systems. Headquarters is in USA.

Share

Ads